Tricuspid stenosis epidemiology and demographics

Tricuspid stenosis Microchapters
Home
Patient Information
Overview
Classification
Pathophysiology
Causes
Differentiating Tricuspid stenosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-ray
Echocardiography and Ultrasound
CT scan
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Tricuspid stenosis epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Tricuspid stenosis epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Tricuspid stenosis epidemiology and demographics
CDC on Tricuspid stenosis epidemiology and demographics
Tricuspid stenosis epidemiology and demographics in the news
Blogs on Tricuspid stenosis epidemiology and demographics
Directions to Hospitals Treating Psoriasis
Risk calculators and risk factors for Tricuspid stenosis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Epidemiology and Demographics

Prevalence

TS is the least common valvular disease. The prevalence of TS in developed countries is low due to the low prevalence of rheumatic heart disease, the most common cause of TS.

The prevalence of TS is higher in developing countries due tot the higher prevalence of rheumatic heart disease.

Mortality/Morbidity

• Mortality is dependent upon the precipitating cause
• Mortality rate is 5%

Race

There does not seem to be any racial predisposition

Sex

• Observed more in women
• Congenital form is slightly more prevalent in men

Age

• Congenital form accounts for 0.3% of all congenital heart diseases
• Due to secondary causes, in the older population, frequency is between 0.3 - 3.2%